Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015


  Request for Sample Report

Executive Summary

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015" provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dry Eye). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Keratoconjunctivitis sicca (Dry Eye). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Keratoconjunctivitis sicca (Dry Eye) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Keratoconjunctivitis sicca (Dry Eye) 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials 30

Prominent Drugs 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Novartis AG 33

Clinical Trial Overview of Novartis AG 33

Allergan, Inc. 37

Clinical Trial Overview of Allergan, Inc. 37

Santen Pharmaceutical Co., Ltd. 40

Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 40

Valeant Pharmaceuticals International, Inc. 42

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 42

Innovative Medical Products 43

Clinical Trial Overview of Innovative Medical Products 43

Otsuka Holdings Co., Ltd. 44

Clinical Trial Overview of Otsuka Holdings Co., Ltd. 44

Merck & Co., Inc. 45

Clinical Trial Overview of Merck & Co., Inc. 45

ORA, Inc. 46

Clinical Trial Overview of ORA, Inc. 46

Pfizer Inc. 47

Clinical Trial Overview of Pfizer Inc. 47

Laboratoires Thea S.A. 48

Clinical Trial Overview of Laboratoires Thea S.A. 48

Clinical Trial Overview of Top Institutes / Government 49

Kyoto Prefectural University of Medicine 49

Clinical Trial Overview of Kyoto Prefectural University of Medicine 49

Keio University 50

Clinical Trial Overview of Keio University 50

University of Texas Southwestern Medical Center at Dallas 51

Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 51

Marshall B. Ketchum University 52

Clinical Trial Overview of Marshall B. Ketchum University 52

Federal University of Sao Paulo 53

Clinical Trial Overview of Federal University of Sao Paulo 53

Massachusetts Eye and Ear Infirmary 54

Clinical Trial Overview of Massachusetts Eye and Ear Infirmary 54

Ophthalmic Consultants of Long Island 55

Clinical Trial Overview of Ophthalmic Consultants of Long Island 55

Instituto Universitario de Oftalmobiologa Aplicada 56

Clinical Trial Overview of Instituto Universitario de Oftalmobiologa Aplicada 56

Wenzhou Medical College 57

Clinical Trial Overview of Wenzhou Medical College 57

Marui Eye Clinic 58

Clinical Trial Overview of Marui Eye Clinic 58

Five Key Clinical Profiles 59

Appendix 83

Abbreviations 83

Definitions 83

Research Methodology 84

Secondary Research 85

About GlobalData 85

Contact Us 85

Disclaimer 85

Source 86

List of Figures

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 84

List of Tables

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Region, 2015* 7

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 37

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 40

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 42

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovative Medical Products, 2015* 43

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 44

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 45

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by ORA, Inc., 2015* 46

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 47

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015* 48

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 49

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2015* 50

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015* 51

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Marshall B. Ketchum University, 2015* 52

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 53

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts Eye and Ear Infirmary, 2015* 54

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthalmic Consultants of Long Island, 2015* 55

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Universitario de Oftalmobiologa Aplicada, 2015* 56

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wenzhou Medical College, 2015* 57

Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Marui Eye Clinic, 2015* 58

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Keratoconjunctivitis sicca (Dry Eye) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Keratoconjunctivitis sicca (Dry Eye), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com